Identification of New Potential Targets for Pancreatic Ductal Adenocarcinoma by Integrated Bioinformatic Analysis
LPAR5, CYP2C18, SERPINH1 and ACSL5 may serve as potential diagnostic, prognostic, and therapeutic targets for PDAC.
Authors
- Yutaro Natsuyama (ORCID: https://orcid.org/0000-0003-3395-4364)
- Rujia Li (ORCID: https://orcid.org/0000-0003-0276-5632)
- Ting Yang (ORCID: https://orcid.org/0000-0001-8872-8749)
- Shuang‐Qin Yi (ORCID: https://orcid.org/0000-0002-9946-7895)
- Yuichi Nagakawa (ORCID: https://orcid.org/0000-0003-1169-8160)
- Jun Li (ORCID: https://orcid.org/0000-0003-1553-8105)
- Ke Ren (ORCID: https://orcid.org/0000-0003-2133-5355)
- Yuhao Zeng
Institutions
- Tokyo Medical University (JP)
- Shanghai Jiao Tong University (CN)
- Shanghai Cancer Institute (CN)
- State Key Laboratory of Oncogene and Related Genes (CN)
- Tokyo Metropolitan University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2024-09-30
- DOI
- https://doi.org/10.21873/anticanres.17254
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.28